FLUNARIZINE IN MIGRAINE PROPHYLAXIS - EFFICACY AND TOLERABILITY OF 5 MG AND 10 MG DOSE LEVELS

被引：20

作者：

CENTONZE, V

MAGRONE, D

VINO, M

CAPORALETTI, P

ATTOLINI, E

CAMPANALE, G

ALBANO, O

机构：

[1] Headache Unit, Department of Internal Medicine, University of Bari, Bari

来源：

CEPHALALGIA | 1990年 / 10卷 / 01期

关键词：

Flunarizine; migraine prophylaxis; side effects;

D O I：

10.1046/j.1468-2982.1990.1001017.x

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

The use of flunarizine, a drug which has proven its efficacy in migraine, is often associated with important side effects. The aim of this paper has been to check their incidence at different dose levels (5 mg vs 10 mg). Our data confirm the occurrence of important side effects (in particular weight gain); on the other hand, they emphasize the dose-dependency of the side effects. © 1990, International Headache Society. All rights reserved.

引用

页码：17 / 24

页数：8

共 30 条

[1]

Amery W.K., Wauquier A., Van Neuten J.M., De Clerk F., Van Reempts J.V., Janssen P.A.J., The anti-migrainous pharmacology of flunarizine (R 14 950), a calcium antagonist, Drug Exptl Clin Res, 7, pp. 1-10, (1981)

[2]

Louis P., A double-blind placebo-controlled prophylactic study of flunarizine (Sibelium) in migraine, Headache, 21, pp. 235-239, (1981)

[3]

Louis P., Spierings E.L.H., Comparison of flunarizine (Sibelium) and pizotifen (Sandomigran) in migraine treatment: a double blind study, Cephalalgia, 2, pp. 197-203, (1982)

[4]

Diamond S., Shenbaum H., Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine, Headache, 23, pp. 39-42, (1983)

[5]

Peroutka S.J., The pharmacology of calcium channel antagonist: a novel class of anti-migraine agents?, Headache, 23, pp. 278-283, (1983)

[6]

Centonze V., Tesauro P., Trizio T., Magrone D., Vino M., Macinagrossa G., Campanozzi F., Altomare E., Attolini E., Albano O., Efficacy and tolerability of flunarizine in the prophylaxis of migraine, Cephalalgia, 5, pp. 163-168, (1985)

[7]

Baldrati A., Albano F., de Carolis P., Sacquegna T., Essential tremor and flunarizine: description of a case, Cephalalgia, 7, (1987)

[8]

Chouza C., Scaramelli A., Caamano J.L., De Medine O., Aljanati R., Romero S., Parkinsonism, tardive dyskinesia, akathisia and depression induced by flunarizine, Lancet, 1, pp. 1303-1304, (1986)

[9]

Meyboom R.H.B., Ferrari M.D., Dieleman B.P., Parkinsonism, tardive dyskinesia, akathisia and depression induced by flunarizine, Lancet, 2, (1986)

[10]

Meyer S.J., Hardenberg J., Clinical effectiveness of calcium entry blockers in prophylactic treatment o migraine and cluster headache, Headache, 23, pp. 266-277, (1983)

← 1 2 3 →